Consolidated Statement Of Cash Flows

KYORIN Pharmaceutical Co., Ltd. - Filing #7731582

Concept 2017-04-01 to
2017-09-30
As at
2017-09-30
As at
2017-03-31
As at
2016-09-30
2016-04-01 to
2016-09-30
As at
2016-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
8,072,000,000 JPY
17,520,000,000 JPY
Interest and dividends received
208,000,000 JPY
198,000,000 JPY
Interest paid
-13,000,000 JPY
-14,000,000 JPY
Income taxes paid
-1,007,000,000 JPY
-3,189,000,000 JPY
Net cash provided by (used in) operating activities
7,260,000,000 JPY
14,514,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,736,000,000 JPY
-672,000,000 JPY
Proceeds from sale of property, plant and equipment
91,000,000 JPY
JPY
Net cash provided by (used in) investing activities
-3,928,000,000 JPY
-3,895,000,000 JPY
Purchase of investment securities
-5,099,000,000 JPY
-5,800,000,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
-399,000,000 JPY
JPY
Proceeds from sale of shares of subsidiaries resulting in change in scope of consolidation
434,000,000 JPY
JPY
Other, net
-77,000,000 JPY
-291,000,000 JPY
Cash flows from financing activities
Dividends paid
-2,831,000,000 JPY
-2,831,000,000 JPY
Proceeds from long-term borrowings
799,000,000 JPY
36,000,000 JPY
Repayments of long-term borrowings
-627,000,000 JPY
-572,000,000 JPY
Net cash provided by (used in) financing activities
-2,685,000,000 JPY
-4,114,000,000 JPY
Other, net
218,000,000 JPY
-747,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-9,000,000 JPY
-526,000,000 JPY
Net increase (decrease) in cash and cash equivalents
637,000,000 JPY
5,978,000,000 JPY
Cash and cash equivalents
43,137,000,000 JPY
42,499,000,000 JPY
51,021,000,000 JPY
45,043,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.